Orphan designation: [Nle4, D-Phe7]-alfa-melanocyte stimulating hormone (afamelanotide) Treatment of erythropoietic protoporphyria, 08/05/2008 Expired

Records of data processing activity for of the EMA's historical archives and opening to the public

European Medicines Agency’s data protection notice for the processing of personal data contained in the Agency’s historical records selected for permanent preservation and opening to the public

Human medicines European public assessment report (EPAR): Wegovy, semaglutide, Date of authorisation: 06/01/2022, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Renvela, sevelamer carbonate, Date of authorisation: 09/06/2009, Revision: 29, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Vaxxon ND Clone , Newcastle disease virus, strain Clone, live attenuated, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Duotic, betamethasone acetate,terbinafine, Status: Authorised

Conversations on Cancer - Pediatric Cancers: Navigating the Challenges Together, Online, European Medicines Agency, Amsterdam, the Netherlands, from 19 November 2024, 15:30 (CET) to 19 November 2024, 16:30 (CET)

Draft concept paper for the development of a guideline on quality aspects of mRNA vaccines for veterinary use

Guideline on quality aspects of mRNA vaccines for veterinary use